Atomi Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.94M Buy
81,491
+57,858
+245% +$3.37M 0.15% 120
2025
Q4
$1.27M Buy
23,633
+12,072
+104% +$581K 0.04% 335
2025
Q3
$521K Buy
11,561
+3,869
+50% +$181K 0.02% 636
2025
Q2
$356K Sell
7,692
-6,331
-45% -$311K 0.01% 731
2025
Q1
$855K Buy
14,023
+1,255
+10% +$73.2K 0.04% 353
2024
Q4
$722K Buy
12,768
+5,593
+78% +$313K 0.04% 352
2024
Q3
$371K Buy
+7,175
New +$337K 0.02% 580
2024
Q2
Sell
-4,264
Closed -$231K 798
2024
Q1
$231K Buy
+4,264
New +$217K 0.02% 623

Other funds holding BMY

Atomi Financial Group's BMY Position: Q1 2026 in Review

Atomi Financial Group increased its Bristol-Myers Squibb (BMY) stake by 245% in Q1 2026, buying an estimated $3.37M and bringing the position to 81,491 shares worth $4.94M. The position accounts for 0.15% of the portfolio, ranked #120.

Atomi Financial Group first reported a position in BMY in Q1 2024 and has held it in 8 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Atomi Financial Group held 81,491 shares of Bristol-Myers Squibb worth $4.94M as of Q1 2026.
  • Atomi Financial Group bought 57,858 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.37M.
  • Bristol-Myers Squibb made up 0.15% of Atomi Financial Group's portfolio in Q1 2026, its #120 holding.
  • Atomi Financial Group first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 8 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Atomi Financial Group's 13F filing for Q1 2026, filed 14 May 2026.